Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE
GENEVA, SWITZARLAND / ACCESSWIRE / October 29, 2024 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...
Hosted on MSN9mon
Which Artificial Sweeteners Are Approved By the FDA?
These are approved to be used as food additives and are considered safe to consume using ... If you have a metabolic condition called phenylketonuria (PKU) your body can’t break down phenylalanine, so ...
pharmaphorum9mon
Synlogic shuts down after PKU drug fails phase 3 trial
PKU is a rare genetic disease that manifests at birth and is marked by an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods. Left untreated ...
Hosted on MSN23y
How Tyrosine, an Amino Acid, Works in the Body
It helps generate brain chemicals called neurotransmitters, including dopamine, epinephrine, and norepinephrine. It shows some evidence of improving focus and mental clarity, especially in stressful ...
Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents
Relief Therapeutics Holding SA / Key word (s): Study results Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents 25-Oct-2024 / 07:00 CET/CEST Release of an ad hoc ...
Study finds one type of food for breakfast 'reduces heart attack and stroke risk'
Going to work on an egg could stave off a heart attack or stroke, according to research. It boosts metabolism - reducing the ...
Understanding orphan drugs: what are they, how are they classified and what are their challenges in the Indian context
Orphan drugs are further classified as approved by regulatory agencies like the U.S. Food and Drug Administration (FDA ...
Tempo2d
Strong Winds in Bantul Kill One: BNPB Reports
The National Disaster Mitigation Agency (BNPB) recorded one fatality from the heavy rain with strong winds that hit Bantul ...
PTC Therapeutics Announces FDA Target Regulatory Action Date For Sepiapterin And Lancet Publication Of Phase 3 Trial Results
"The Lancet publication reflects the promising and transformative nature of the data collected to date on sepiapterin and the therapy's potential to fill the persistent and significant unmet medical ...
Future Market Insights8d
Global Primary Hyperoxaluria Treatment Market Expected to Reach USD 41.07 Million by 2033 at a 8.6% CAGR, Driven by Advances in Therapeutics
The global primary hyperoxaluria (PH) treatment market is projected to achieve a market value of USD 18 million in 2023, with ...
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session – – Tebapivat Phase 1 Data in Sickle Cell Disease and Phase 2b ...
生物通24d
【科研动态】华中科技大学生命学院宁康教授团队《JAMA Network Open》：让大数据为“不食人间烟火的孩子”...
相关工作在2024年6月5日以“ Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China ”为题发表在医学领域著名学术期刊 JAMA Network Open （中科院一区 Top ） 世界上有一群特殊的 ...